L01EX Other protein kinase inhibitors Other protein kinase inhibitors Other protein kinase inhibitors Other protein kinase inhibitors L4
Source: Wikipedia · CC BY-SA 4.0 Fuente: Wikipedia · CC BY-SA 4.0 · nombre de respaldo (en) 来源:维基百科 · CC BY-SA 4.0 · 回退名 (en) 來源:維基百科 · CC BY-SA 4.0 · 回退名 (en)
ATC level L4 · Search this class · Consumer categories
Active ingredients in this class
40 active ingredients 40 principios activos 40 个活性成分 40 個有效成分
The market codes after a status are the markets where that status is recorded (same codes as the product tables). An ingredient can be on sale in one market and withdrawn in another; that is a record fact, not a safety judgement.
- 乙磺酸尼达尼布
L01EXactiveCN - 伯瑞替尼
L01EXactiveCN - 培唑帕尼
L01EXactiveCN - 塞普替尼
L01EXactiveCN - Gilteritinib
L01EX13Salt form: Gilteritinib FumarateactiveUS·GB·CA·AU·SG·CN·ES·TW·EUunknownAU·HK - 富马酸安奈克替尼
L01EXactiveCN - 己二酸他雷替尼
L01EXactiveCN - Entrectinib
L01EX14activeUS·GB·CA·AU·SG·CN·ES·TW·EUunknownAU·HK - 普拉替尼
L01EXactiveCN - 氟泽雷塞
L01EXactiveCN - Regorafenib
L01EX05activeUS·GB·CA·SG·CN·ES·TW·EUunknownAU·HK - Ripretinib
L01EX19activeUS·GB·CA·AU·SG·CN·ES·TW·EUunknownAU·HK - 瑞派替尼
L01EXactiveCN - Lenvatinib
L01EX08discontinuedES·MXactiveUS·GB·CA·AU·SG·CN·ES·MX·TW·EUunknownAU·HK - 甲苯磺酸多纳非尼
L01EXactiveCN - Sorafenib
L01EX02withdrawnESdiscontinuedES·MXactiveUS·GB·CA·AU·SG·CN·ES·MX·TW·EUunknownHK - 盐酸卡马替尼
L01EXactiveCN - 盐酸特泊替尼
L01EXactiveCN - 硫酸拉罗替尼
L01EXactiveCN - 苹果酸舒尼替尼
L01EXactiveCN - 谷美替尼
L01EXactiveCN - 赛沃替尼
L01EXactiveCN - 阿伐替尼
L01EXactiveCN - Avapritinib
L01EX18activeUS·GB·CA·ES·TW·EUunknownHK - Cabozantinib
L01EX07Salt form: Cabozantinib-MalatediscontinuedES·MXactiveGB·CA·AU·SG·ES·TW·EUunknownAU·HK - Capivasertib
L01EX27discontinuedESactiveUS·GB·CA·AU·SG·MX·TW·EUunknownAU·HK - Larotrectinib
L01EX12Salt form: Larotrectinib SulfatewithdrawnESactiveUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Midostaurin
L01EX10activeUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Nintedanib
L01EX09discontinuedESactiveGB·AU·SG·ES·MX·EUunknownHK - Nintedanib Esilate
L01EX09activeCAunknownAU - Pazopanib
L01EX03discontinuedCAactiveUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Pexidartinib
L01EX15activeUSunknownEU - Pralsetinib
L01EX23withdrawnES·EUdiscontinuedCAactiveUS·GB·TWunknownHK - Quizartinib
L01EX11activeUS·GB·CA·ES·TW·EUunknownHK·EU - Repotrectinib
L01EX28discontinuedCAactiveUS·AU·TW·EUunknownAU·HK - Selpercatinib
L01EX22discontinuedESactiveUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Sunitinib
L01EX01Salt form: Sunitinib MalatewithdrawnESdiscontinuedCA·ES·MXactiveUS·GB·CA·AU·SG·ES·MX·TW·EUunknownAU·HK - Tepotinib
L01EX21Salt form: Tepotinib Hydrochloride MonohydrateactiveUS·GB·CA·AU·SG·ES·TW·EUunknownAU·HK - Vandetanib
L01EX04activeUS·GB·CA·ES·TW·EUunknownAU·HK - Vimseltinib
L01EX29discontinuedESactiveUS·EU
By dosage form, across markets
An ATC class only groups medicines by similar pharmacology/chemistry — it does not mean they are interchangeable. A different ingredient, dosage form, release mechanism or strength is not interchangeable.
Only ingredients with a recorded ATC class are listed (6,009 of 12,637).
Class names are editorial translations or come from Wikipedia (CC BY-SA 4.0) / Wikidata (CC0); each ATC page lists the exact source, licence and link for every language. Only the ATC code and the WHO hierarchy are authoritative.
Notes & licences
Status badges summarise the product records held for each ingredient (active / discontinued / withdrawn / unknown), and the market codes after each badge show where that status is recorded. Only some registers publish a status column: CA, ES and MX do; AU and HK have no status column and are recorded as unknown; CN, US, GB, TW and SG records are on the register and marked active.
Class and category names are editorial or AI-assisted translations; only the ATC code and the WHO hierarchy are authoritative.
ATC codes and hierarchy reference the WHO Collaborating Centre for Drug Statistics Methodology ATC/DDD Index (copyright WHOCC; the index itself is not reproduced). Ingredient/strength facts come from the regulator records listed on About.